BiomX Acquires 10% of MEA Testing Systems; Option for Majority

BiomX Inc. entered into a Share Purchase and Option Agreement with Mayers Ventures LLC to acquire a 10% equity interest in M.E.A. Testing Systems Ltd. (MEA) and its affiliated company in India. The consideration for this initial stake includes $50,000 in cash and 1,300,000 restricted BiomX common shares. This acquisition is intended to enhance BiomX's capabilities in supporting integrated defense systems by gaining expertise in electric propulsion. Additionally, BiomX secured an exclusive option, exercisable through June 30, 2028, to acquire Mayers' remaining approximately 78.9% holdings in the MEA Companies, with the purchase price based on a multiple of 2027 net revenue or EBITDA.